Upgrade to SI Premium - Free Trial

Adient (ADNT) PT Lowered to $32 at JPMorgan

May 7, 2024 6:02 AM
JPMorgan analyst Ryan Brinkman lowered the price target on Adient (NYSE: ADNT) to $32.00 (from $37.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles